Sort   by:  
 Page size 
UnknownAntiemetics: American Society of Clinical Oncology clinical practice guideline update.
Not available
S-EPMC4876353 | biostudies-literature
UnknownGenetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program.
Not available
S-EPMC3431328 | biostudies-literature
UnknownEuropean Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations.
Not available
S-EPMC7437085 | biostudies-literature
UnknownAmyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.
Not available
S-EPMC4553028 | biostudies-literature
UnknownTwo phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618 | biostudies-literature
UnknownConfirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults.
Not available
S-EPMC3594066 | biostudies-literature
UnknownSociodemographic, Clinical, and Psychosocial Predictors of Short- and Long-term Study Retention in the Diabetes Prevention Program (DPP) Outcomes Study (DPPOS).
Not available
S-EPMC12451849 | biostudies-literature
UnknownShort and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherence.
Not available
S-EPMC4015875 | biostudies-literature
UnknownHealth effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
Not available
S-EPMC6899507 | biostudies-literature
UnknownEffects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.
Not available
S-EPMC3439414 | biostudies-literature
Sort   by:  
 Page size